Arterial hypertension and cerebrovascular damage
DOI:
https://doi.org/10.67667/NEU.v25i1.156Keywords:
arterial hypertension, central nervous system, risk factorsAbstract
Cardiovascular diseases are a leading cause of increased morbidity and mortality worldwide, and arterial hypertension is a leading risk factor for this. Although it is now a manageable problem, a large percentage of patients do not reach blood pressure targets. The reason for this is the heterogeneity in etiology and pathogenesis of the disease.
Elevated blood pressure has an extremely adverse effect on the brain, it is a major risk factor not only for hemorrhagic, ischemic and recurrent stroke, but also for cognitive disorders.
References
Стефанова, И., Кузманова, Р. Оценка на риска за пациенти с епилепсия и артериална хипертония. Двигателни нарушения, 2018, 15, 1, 24-28. [Risk assessment among patients with epilepsy and arterial hypertension. Movement Disorders, 2018, 15, 1, 24-28.] https://www.multiplesclerosis-bg.com/journal/index.php/md/article/view/22
Стефанова, И., Кузманова, Р. Оценка на риска за пациенти с епилепсия и захарен диабет. Cephalgia, 2017, 19, 1, 8-11. [Stefanova, I., Kuzmanova, R. Risk assessment among patients with epilepsy and diabetes mellitus . Cephalgia, 2017, 19, 1, 8-11.] https://glavobolie.org/journal/index.php/ce/article/view/24
Стефанова, И., Колев, П., Кузманова, Р. Коморбидност на епилепсия и артериална хипертония. Двигателни нарушения, 2013, 10, 2, 47-51. [Stefanova, I., Kolev., P., Kuzmanova, R. Comorbidity of epilepsy and arterial hypertension, 2013, 10, 2, 47-51.] https://www.multiplesclerosis-bg.com/journal/index.php/md/issue/view/18/18
Anderson, C.S., Heeley, E., Huang, Y., Wang, J., Stapf, C., Delcourt, C., Lindley, R., Robinson, T., Lavados, P., Neal, B., Hata, J., Arima, H., Parsons, M., Li, Y., Wang, J., Heritier, S., Li, Q., Woodward, M., Simes, R.J., Davis, S.M., Chalmers, J. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med, 2013, 368, 2355-2365.
Ettehad, D., Emdin, C.A., Kiran, A., Anderson, S.G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., Rahimi, K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet, 2016, 387, 957-967.
Harder, D.R., Smeda, J., Lombard, J. Enhanced myogenic depolarization in hypertensive cerebral arterial muscle. Circ. Res. 1985, 57, 319-322.
Harrison, D.G., Coffman, T.M., Wilcox, C.,S. Pathophysiology of Hypertension. The Mosaic Theory and Beyond. Circulation, 2021, 128, 7, 847-863.
Kennelly, S.P., Lawlor, B.A., Kenny, R., A. Blood pressure and dementia – a comprehensive review. Ther. Adv. Neurol. Disord, 2009, 2, 241-260.
Kernan, W. N., Ovbiagele, B., Black, H.R., Bravata, D.M., Chimowitz, M. I., Ezekowitz, M.D., Fang, M.C., Fisher, M., Furie, K.L., Heck, D.V., Johnston, S.C., Kasner, S.E., Kittner, S.J, Mitchell, P.H., Rich, M.W., Richardson, D., Schwamm, L.H., Wilson, J.A., American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014, 45, 2160-2236.
Kivipelto, M. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ, 2001, 322, 1447-1451.
Launer, L.J. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging, 2000, 21, 49-55.
Lee, M., Ovbiagele, B., Hong, K.S., Wu, Y.L., Lee, J.E., Rao, N.M,., Feng, W., Saver, J.L. Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke 2015, 46, 1883-1889.
NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 2021, 398, 957-80.
PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl), 1995, 108, 710-717.
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001, 358, 1033-1041.
PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001, 358, 1033-1041.
The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. NEJM, 2015, 373, 22.
Thomopoulos, C., Parati, G, Zanchetti, A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels -updated overview and metaanalyses of randomized trials. J Hypertens 2016, 34, 613-622.
Toth, P. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J. Cereb. Blood Flow. Metab. 2013, 33, 1732-1742.
Toth, P. Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell 2015, 14, 400-408.
Toth, P. Role of 20-HETE, TRP channels and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. Am. J. Physiol. Heart Circ. Physiol., 2013, 305, 1698-1708.
Ungvari, Z., Toth, P. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nature Reviews Nephrology, 2021, 17, 639-654.
Walker, K.A. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA, 2019, 322, 535-545.
Whitmer, R.A., Sidney, S., Selby, J., Johnston, S. C., Yaffe, K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 2005, 64, 277-281.
Wilkie, F.L., Eisdorfer, C. & Nowlin, J. B. Memory and blood pressure in the aged. Exp. Aging Res. 1976, 2, 3-16.
Williams B, Mancia G, Spiering W. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal, 2018, 39, 33, 3021-3104.
Downloads
Published
How to Cite
Issue
Section
ARK
License
Copyright (c) 2024 B. Krustev
This work is licensed under a Creative Commons Attribution 4.0 International License.
